Statins don’t appear to compromise effectiveness of abiraterone
SAN FRANCISCO – Statins do not reduce the effectiveness of abiraterone acetate in men with castration-resistant prostate cancer, and they may even prove to add to therapy, according to data reported...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Cholesterol | Endocrinology | Prostate Cancer | Statin Therapy